Publications of Felix Dietlein

Schöttle, J.; Chatterjee, S.; Volz, C.; Siobal, M.; Florin, A.; Rokitta, D.; Hinze, Y.; Dietlein, F.; Plenker, D.; König, K. et al.; Albus, K.; Heuckmann, J. M.; Rauh, D.; Franz, T.; Neumaier, B.; Fuhr, U.; Heukamp, L. C.; Ullrich, R. T.: Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer. Oncotarget 6 (36), pp. 38458 - 38468 (2015)

Malchers, F.; Dietlein, F.; Schöttle, J.; Lu, X.; Nogova, L.; Albus, K.; Fernandez-Cuesta, L.; Heuckmann, J. M.; Gautschi, O.; Diebold, J. et al.; Plenker, D.; Gardizi, M.; Er, M. S.; Bos, M.; Seidel, D.; Leenders, F.; Richters, A.; Peifer, M.; Florin, A.; Mainkar, P. S.; Karre, N.; Chandrasekhar, S.; George, J.; Silling, S.; Rauh, D.; Zander, T.; Ullrich, R. T.; Reinhardt, H. C.; Ringeisen, F.; Buettner, R.; Heukamp, L. C.; Wolf, J.; Thomas, R. K.: Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer. Cancer Discovery 4 (2), pp. 246 - 257 (2014)

Scheffler, M.; Zander, T.; Nogova, L.; Kobe, C.; Kahraman, D.; Dietlein, F.; Papachristou, I.; Heukamp, L.; Büttner, R.; Boellaard, R. et al.; Lammertsma, A. A.; Querings, S.; Stoelben, E.; Engel-Riedel, W.; Neumaier, B.; Wolf, J.: Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with Erlotinib. PLoS ONE 8 (1), e53081 (2013)

Sos, M. L.; Dietlein, F.; Peifer, M.; Schöttle, J.; Balke-Want, H.; Müller, C.; Koker, M.; Richters, A.; Heynck, S.; Malchers, F. et al.; Heuckmann, J. M.; Seidel, D.; Eyers, P. A.; Ullrich, R. T.; Antonchik, A. P.; Vintonyak, V. V.; Schneider, P. M.; Ninomiya, T.; Waldmann, H. H.; Büttner, R.; Rauh, D.; Heukamp, L.; Thomas, R. K.: A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America 109 (42), pp. 17034 - 17039 (2012)